ANTINEO, winner of the France 2030 call for projects !
We are proud to announce that ANTINEO has been selected as part of the France 2030 initiative to lead a project that is both deeply innovative and impactful.
Our ambition : To improve the predictability of responses to anticancer treatments while significantly reducing the use of animal models.
How ? By leveraging a disruptive approach based on 3D bioprinting of in-vitro tumor models derived from patient tumors.
This project aims to:
- Faithfully recreate the tumor microenvironment for more relevant preclinical models,
- Accelerate the development of innovative cancer therapies,
- Reduce the use of animal models,
- Promote more ethical, standardized, and reproducible research practices.
A heartfelt thank you to the Région Auvergne-Rhône-Alpes and the France 2030 initiative for their trust and support.
